HOME >> BIOLOGY >> NEWS
ACS News Service weekly press package - May 30, 2006

ely unexpected discovery that ozone may be produced in the body. Ozone is a high-energy form of oxygen most familiar as an air pollutant. That research showed that ozone can cause pathological changes in cholesterol and other molecules in the body. The changes produce toxic compounds called "atheronals" that are present in atherosclerotic plaques removed from patients with blood vessel disease.

In their new research, scheduled for publication in the June 13 issue of Biochemistry, Paul Wentworth, Jr., and colleagues report that atheronals do have the potential to cause plaques. Atheronals accelerate or stimulate a number of processes regarded as critical for formation of atherosclerotic plaques, they found.

The Biochemistry report raises the possibility that atheronals may originate in part from ozone inhaled into the lung from polluted air. "As such, the atheronals may be a heretofore unrecognized chemical player in the known linkage between environmental pollution and cardiovascular disease," the report states.

ARTICLE #1
"Proatherogenic Effects of the Cholesterol Ozonolysis Products, Atheronal-A and Atheronal-B."

DOWNLOAD PDF:
http://pubs.acs.org/cgi-bin/sample.cgi/bichaw/asap/pdf/bi0604330.pdf
DOWNLOAD HTML:
http://pubs.acs.org/cgi-bin/sample.cgi/bichaw/asap/html/bi0604330.html

CONTACT:
Paul Wentworth, Jr., Ph.D., FRSC
The Scripps Research Institute
Phone: 858-784-2576
Fax: 858-784-2593
Email: paulw@scripps.edu, paul.wentworth@bioch.ox.ac.uk

ARTICLE #2

A dozen cloves of garlic a day keeps the doctor away?
Journal of Agricultural & Food Chemistry

The classic fairy tale Goldilock
'"/>

Contact: Michael Woods
m_woods@acs.org
202-872-4400
American Chemical Society
30-May-2006


Page: 1 2 3 4 5 6 7

Related biology news :

1. ACS News Service Weekly PressPac -- May 23, 2007
2. ACS News Service Weekly PressPac -- May 16, 2007
3. ACS News Service Weekly PressPac -- May 9, 2007
4. ACS News Service Weekly PressPac -- May 2, 2007
5. ACS News Service Weekly PressPac -- April 25, 2007
6. ACS News Service Weekly PressPac -- April 18, 2007
7. ACS News Service Weekly PressPac -- April 11, 2007
8. ACS News Service Weekly PressPac -- March 28, 2007
9. ACS News Service Weekly PressPac -- March 21, 2007
10. ACS News Service Weekly PressPac -- March. 14, 2007
11. ACS News Service Weekly PressPac -- Feb. 21, 2007

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: ACS News Service weekly press package May

(Date:7/27/2015)... 2015  Synaptics Inc. (NASDAQ: SYNA ), ... announced that Huawei has selected the Synaptics ® ... stylish smartwatch. Huawei chose the state-of-the-art ClearPad capacitive ... and highly responsive human interface qualities such as ... required a classic round watch face and Synaptics ...
(Date:7/27/2015)... July 27, 2015   Zynx Health ™, ... clinical improvement solutions, today announced that its ... available on Android smartphones and tablets. With this ... organizations can use ZynxCarebook to securely exchange messages ... streamline care transitions to other care settings, and ...
(Date:7/23/2015)... -- Aware, Inc. (NASDAQ: AWRE ), a leading supplier ... its second quarter ended June 30, 2015.  ... a decrease of 33% compared to $6.8 million in the ... of 2015 was $0.3 million, or $0.01 per diluted share, ... in the same period a year ago.  ...
Breaking Biology News(10 mins):Synaptics Touchscreen Solution Powers New Huawei Watch 2Synaptics Touchscreen Solution Powers New Huawei Watch 3Zynx Health Adds Android Device Support to ZynxCarebook Solution 2Zynx Health Adds Android Device Support to ZynxCarebook Solution 3Aware, Inc. Reports Second Quarter 2015 Financial Results 2Aware, Inc. Reports Second Quarter 2015 Financial Results 3Aware, Inc. Reports Second Quarter 2015 Financial Results 4Aware, Inc. Reports Second Quarter 2015 Financial Results 5Aware, Inc. Reports Second Quarter 2015 Financial Results 6
(Date:7/27/2015)... YORK , July 27, 2015 ... today announced the winners of its annual Klerman ... research by scientists who have been supported by ... career scientists to pursue innovative ideas in neurobiological ... "proof" of concept for the early detection, treatment, ...
(Date:7/26/2015)... (PRWEB) , ... July 26, 2015 , ... ... of its VALIDATE® ANEMIA calibration verification / linearity test kit. The VALIDATE® ANEMIA ... Each VALIDATE® ANEMIA kit is prepared using the CLSI recommended “equal delta” method ...
(Date:7/24/2015)... 2015 Equity Research Institute has ... (NASDAQ: PDLI ), Arena Pharmaceuticals Inc. (NASDAQ: ... Biotherapeutics Inc. (NASDAQ: NWBO ), and Acorda Therapeutics ... PDL BioPharma can be accessed at https://www.EquityResearchInstitute.com/reports?keyword=PDLI ... at 5,146.41, down 0.49%, the Dow Jones Industrial Average ...
(Date:7/24/2015)... 24, 2015 The global ... USD 27.8 billion by 2022, growing at an estimated ... a new study by Grand View Research, Inc. Development ... to result in significant reduction in cost of sequencing ... and usage rates of next generation sequencing throughout the ...
Breaking Biology Technology:Brain & Behavior Research Foundation Names Winners of Klerman-Freedman Prizes for Exceptional Research 2Brain & Behavior Research Foundation Names Winners of Klerman-Freedman Prizes for Exceptional Research 3Brain & Behavior Research Foundation Names Winners of Klerman-Freedman Prizes for Exceptional Research 4Brain & Behavior Research Foundation Names Winners of Klerman-Freedman Prizes for Exceptional Research 5Brain & Behavior Research Foundation Names Winners of Klerman-Freedman Prizes for Exceptional Research 6Maine Standards Company, LLC Announces Release of VALIDATE® ANEMIA Calibration Verification / Linearity Test Kit 2Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics 2Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics 3Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics 4Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics 5Next Generation Sequencing (NGS) Market To Reach $27.8 Billion By 2022: Grand View Research, Inc. 2Next Generation Sequencing (NGS) Market To Reach $27.8 Billion By 2022: Grand View Research, Inc. 3Next Generation Sequencing (NGS) Market To Reach $27.8 Billion By 2022: Grand View Research, Inc. 4Next Generation Sequencing (NGS) Market To Reach $27.8 Billion By 2022: Grand View Research, Inc. 5
Cached News: